arrow
J

Jiaoti Huang

Duke University
H指数:90
被引数:2.6万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Programmable mRNA 3′UTR engineering restores MHC-I and overcomes immune evasion in prostate cancer

可编程mRNA 3'utr工程恢复mhc-i并克服前列腺癌中的免疫逃避

2026-06-160
PRE
Corrigendum to “RNA Splicing of the BHC80 Gene Contributes to Neuroendocrine Prostate Cancer Progression” [Eur. Urol. 76(2) (2019) 157–166]

勘误:“BHC80基因的RNA剪接促进神经内分泌前列腺癌进展”[Eur. Urol. 76(2) (2019) 157–166]

2025-05-080
OA
Genetic ancestry concordant RNA splicing in prostate cancer involves oncogenic genes and associates with recurrence

前列腺癌中与遗传谱系一致的RNA剪接涉及癌基因并与复发相关

2025-01-290
OA
Tucidinostat and metronomic capecitabine plus endocrine therapy for patients with HR+/HER2-advanced breast cancer after CDK4/6 inhibitors: Preliminary findings of a multi-center, phase II study

Tucidinostat和间质卡培他滨联合内分泌疗法用于接受CDK4/6抑制剂治疗后的人表皮生长因子受体2阴性、激素受体阳性晚期乳腺癌患者的初步结果:一项多中心、II期研究。

2024-09-010
PRE
UCHL1 is a molecular indicator and a therapeutic target for neuroendocrine carcinomas
2024-03-220
PRE
UCHL1 is a potential molecular indicator and therapeutic target for neuroendocrine carcinomas

UCHL1是神经内分泌癌的潜在分子指标和治疗靶点

2024-02-0110
OAAI
CHRM4/AKT/MYCN upregulates interferon alpha-17 in the tumor microenvironment to promote neuroendocrine differentiation of prostate cancer (vol 14, 304, 2023)

CHRM4/AKT/MYCN在肿瘤微环境中上调干扰素 α-17促进前列腺癌的神经内分泌分化 (第14卷,304,2023)

2024-01-291
OAAI